Communihealth Services - Medicare Mental Health Clinic in Bastrop, LA

Communihealth Services is a medicare enrolled mental health clinic (Family Medicine) in Bastrop, Louisiana. The current practice location for Communihealth Services is 314 N Franklin St, Bastrop, Louisiana. For appointments, you can reach them via phone at (318) 283-8887. The mailing address for Communihealth Services is Po Box 792, Bastrop, Louisiana and phone number is (318) 239-8026.

Communihealth Services is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1053373191. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (318) 283-8887.

Contact Information

Communihealth Services
314 N Franklin St
Bastrop
LA 71220-3846
(318) 283-8887
(318) 281-6339

Mental Health Clinic Profile

Full NameCommunihealth Services
SpecialityFamily Medicine
Location314 N Franklin St, Bastrop, Louisiana
Authorized Official Name and PositionKatie Parnell (CEO)
Authorized Official Contact3182398026
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Communihealth Services
Po Box 792
Bastrop
LA 71221-0792

Ph: (318) 239-8026
Communihealth Services
314 N Franklin St
Bastrop
LA 71220-3846

Ph: (318) 283-8887

NPI Details:

NPI Number1053373191
Provider Enumeration Date04/04/2006
Last Update Date07/26/2023
Certification Date07/26/2023

Medicare PECOS Information:

Medicare PECOS PAC ID1254343593
Medicare Enrollment IDO20060703000063

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Communihealth Services such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053373191NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101Y00000XCounselor (* (Not Available))Secondary
122300000XDentist (* (Not Available))Secondary
207Q00000XFamily Medicine (* (Not Available))Primary
208000000XPediatrics (* (Not Available))Secondary
261QF0400XClinic/center - Federally Qualified Health Center (fqhc) (* (Not Available))Secondary
363L00000XNurse Practitioner (* (Not Available))Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Communihealth Services acts as a billing entity for following providers:
Provider NameRhonda A Beard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1568464733
PECOS PAC ID: 1850288523
Enrollment ID: I20040228000224

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameLaurie L Hamilton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154549079
PECOS PAC ID: 4981699444
Enrollment ID: I20040415000870

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameMamdouh G Mickail
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1548327372
PECOS PAC ID: 1850327651
Enrollment ID: I20050713000360

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameBenjamin Hayden
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1841236437
PECOS PAC ID: 3870527799
Enrollment ID: I20050921000032

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameDaniel Trejo
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1093766925
PECOS PAC ID: 2062480486
Enrollment ID: I20060331000051

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameShahzad M Malik
Provider TypePractitioner - Pediatric Medicine
Provider IdentifiersNPI Number: 1083653620
PECOS PAC ID: 2769494004
Enrollment ID: I20060703000090

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameSherryl Lynn Dunlap
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1285711762
PECOS PAC ID: 2769482850
Enrollment ID: I20070115000325

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameRena Braswell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1821180142
PECOS PAC ID: 9436251543
Enrollment ID: I20070220000664

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameDouglas R Council
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144250606
PECOS PAC ID: 2567568272
Enrollment ID: I20070507000527

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameNaomi Smith
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265461677
PECOS PAC ID: 3577664390
Enrollment ID: I20070724000438

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameCarolyn Kelly-jones
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255470837
PECOS PAC ID: 9931290673
Enrollment ID: I20070809000219

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameTammy H Parker
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720156557
PECOS PAC ID: 4284783242
Enrollment ID: I20090521000244

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameApril F Howard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972730646
PECOS PAC ID: 2062568611
Enrollment ID: I20090923000189

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameHeather Hollis Davis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1346505393
PECOS PAC ID: 8022265115
Enrollment ID: I20120824000208

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJason R Hoskins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1447508817
PECOS PAC ID: 9436307154
Enrollment ID: I20120920000657

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameWilliam K Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013340744
PECOS PAC ID: 0547497703
Enrollment ID: I20131213000205

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameLori A Farr
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326428905
PECOS PAC ID: 6002121282
Enrollment ID: I20150817002816

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameMary W Rachal
Provider TypePractitioner - Oral Surgery
Provider IdentifiersNPI Number: 1801275573
PECOS PAC ID: 3971800665
Enrollment ID: I20160323001879

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NamePamela Suzette Eisler
Provider TypePractitioner - Certified Nurse Midwife (cnm)
Provider IdentifiersNPI Number: 1699138867
PECOS PAC ID: 8325347313
Enrollment ID: I20160426000296

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameSharlene Sullivan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013437086
PECOS PAC ID: 1850662636
Enrollment ID: I20170814000715

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameTamatha Yvette Hawkins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871004028
PECOS PAC ID: 5092074096
Enrollment ID: I20180122000125

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameElizabeth A Hoskins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144728494
PECOS PAC ID: 0941561948
Enrollment ID: I20180308001950

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameGregory Renck
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1275645400
PECOS PAC ID: 2668557455
Enrollment ID: I20180723000222

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameCynthia Polk
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1720391188
PECOS PAC ID: 2961724299
Enrollment ID: I20180925001665

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameMunira A Yusuf
Provider TypePractitioner - Pediatric Medicine
Provider IdentifiersNPI Number: 1386707362
PECOS PAC ID: 5799036042
Enrollment ID: I20180925003348

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameChristin N Powell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548426588
PECOS PAC ID: 4183976418
Enrollment ID: I20181015000717

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameBrenton Lee Albritton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1770065799
PECOS PAC ID: 4082967609
Enrollment ID: I20181030000563

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJoseph Hime
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1528324811
PECOS PAC ID: 8123337201
Enrollment ID: I20181226002001

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJennifer Prichard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154980977
PECOS PAC ID: 8729315445
Enrollment ID: I20190802002375

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameDanita Renae Potter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073167573
PECOS PAC ID: 4587992664
Enrollment ID: I20190828000013

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameIngrid G Cook
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1821301912
PECOS PAC ID: 1153652060
Enrollment ID: I20191008000579

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameLanell Younger
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1992331524
PECOS PAC ID: 2365863313
Enrollment ID: I20200601000707

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameMehran Rastegar-lari
Provider TypePractitioner - Dentist
Provider IdentifiersNPI Number: 1154380848
PECOS PAC ID: 6507191004
Enrollment ID: I20201001002694

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameMegan D Pipes
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942825823
PECOS PAC ID: 9032524038
Enrollment ID: I20210225002309

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameRhonda Terese Rushing
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942894464
PECOS PAC ID: 6608285762
Enrollment ID: I20210503001094

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameSimone Trahan Mcmillon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134796584
PECOS PAC ID: 5698177079
Enrollment ID: I20210707002989

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameLindsay Leeper
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861064560
PECOS PAC ID: 1850795816
Enrollment ID: I20210812002170

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameDianna Lynn Adams
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407440217
PECOS PAC ID: 8820480049
Enrollment ID: I20220121000005

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJessica Buck
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1912630377
PECOS PAC ID: 4880075811
Enrollment ID: I20220721001566

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameCierra January
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1841860798
PECOS PAC ID: 3971974817
Enrollment ID: I20230201000110

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJohnny Earl Bryan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1891370722
PECOS PAC ID: 3971976960
Enrollment ID: I20230221003411

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJacob Turnbull
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1962853473
PECOS PAC ID: 1658669858
Enrollment ID: I20230222002553

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameChristopher J Clark
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1194286955
PECOS PAC ID: 3678980869
Enrollment ID: I20230301000582

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameKristal Ladawn Atkins-hayman
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1821532573
PECOS PAC ID: 5496103574
Enrollment ID: I20231213002759

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameShelby Deason Smith
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1659736809
PECOS PAC ID: 0749630960
Enrollment ID: I20231229000597

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameTiffany K Hatfield
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1801136072
PECOS PAC ID: 5799135927
Enrollment ID: I20231229000825

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameStacey Smith Ogden
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073395521
PECOS PAC ID: 6608226857
Enrollment ID: I20231229001587

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameRita Lynn Mcmaster
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1861865248
PECOS PAC ID: 6507294469
Enrollment ID: I20240104002453

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameElizabeth Rose Fuller
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1285902650
PECOS PAC ID: 7810348786
Enrollment ID: I20240105000406

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameKacey Tyson Tubbs
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1720350457
PECOS PAC ID: 4789035551
Enrollment ID: I20240105000605

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameAlexis Ariel Smith Allen
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1649630872
PECOS PAC ID: 4789034935
Enrollment ID: I20240111003117

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

Provider NameJeremy Thornhill
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1811464233
PECOS PAC ID: 7719320084
Enrollment ID: I20240205000885

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more Medical News

› Verified 4 days ago

News Archive

Tony Blair participates in the work of Muslim-Christian alliance in Africa led by NIFAA

This afternoon Tony Blair participated in the work of the largest Muslim-Christian alliance in Africa led by the Nigerian Inter-Faith Action Association (NIFAA), with funding support from the Nigerian government, the World Bank, the Center for Interfaith Action on Global Poverty (CIFA), and other international funders.

Study finds reporting heart procedure results can limit use

The research in the Journal of the American Medical Association shows that in states that report outcomes from procedures to open blocked arteries, patients are less likely to get the treatment. However, they found no differences in patient survival.

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

Researchers develop deep-learning based method to predict onset of Alzheimer's disease

According to World Health Organisation, Alzheimer's disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come.

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

Read more News

› Verified 4 days ago

Family Medicine in Bastrop, LA

Therapeutic Interventions
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 9080 Westwood Dr., Null, Bastrop, LA 71220
Phone: 318-237-8000    
Communihealth Services
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 314 North Franklin Street, Bastrop, LA 71220
Phone: 318-283-8887    
Obh-bastrop Addictive Disorders Clinic
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 320 S Franklin St, Bastrop, LA 71220
Phone: 318-283-0868    Fax: 318-283-0875
The Carter House For Youth
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 406 Tisdale Dr, Bastrop, LA 71220
Phone: 318-974-6000    
Body & Soul Rehabilitation Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 803 Brisco Ave, Bastrop, LA 71220
Phone: 318-283-3299    
Abounding Grace Therapeutic Solutions
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 202 N Vine St, Bastrop, LA 71220
Phone: 318-281-4195    Fax: 318-281-4196

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.